EMS-CHEMIE (EMSN) Q2 2026 earnings summary

Executive summary

• Achieved successful growth with innovative, high-margin new business across all regions and future technologies, despite a challenging geopolitical and economic environment.

• Sales volumes and operating income (EBIT) increased compared to the previous year, supported by proactive planning and a focus on specialties and innovation.

• Maintained global delivery reliability and prepared for international trade barriers, with most US sales produced locally or exempt from tariffs.

Financial highlights

• Net sales reached CHF 1,012 million for H1 2026, a 4.5% increase in local currencies year-over-year.

• EBIT rose to CHF 310 million, up 4.7% from the previous year; EBIT margin improved to 30.6% from 29.1%.

• EBITDA increased to CHF 336 million, up 3.9% year-over-year; EBITDA margin rose to 33.2% from 31.7%.

• Total dividend proposed at CHF 18.40 per share, including an ordinary dividend of CHF 14.65 and an extraordinary dividend of CHF 3.75.

Outlook and guidance

• Expects a continuing challenging geopolitical environment and possible further appreciation of the Swiss franc.

• Slightly raises net sales forecast for 2026, but expects full-year net sales slightly below previous year due to currency effects.

• Operating income (EBIT) for 2026 expected to be slightly above previous year.